Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Urate Lowering Therapy on Blood Pressure in Young Adults
NCT02038179Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2014
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of allopurinol in hypertension (HTN) and prehypertension (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Change in Systolic Blood Pressure at 4 weeks, Change in Flow-mediated Arterial Vasodilation at 4 weeks and 1 more. Started Jul 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
hypertension (HTN)prehypertension
Beyond the preview
Go deeper on NCT02038179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038179.